Status:
UNKNOWN
Metoclopramide for Gastric Visualization in Active Upper GI Bleeding
Lead Sponsor:
King Chulalongkorn Memorial Hospital
Conditions:
Upper GI Bleeding
Eligibility:
All Genders
18+ years
Phase:
PHASE4
Brief Summary
This study aim to evaluate the efficacy of metoclopramide for gastric visualization in patients with active UGIB. This is a double-blinded, multicenter RCT. Patients with 'active' UGIB (hematemesis or...
Detailed Description
* This is double-blinded, multicenter RCT including six hospitals in Thailand. * The participated endoscopists had work experience for endoscopy more than three years. * All endoscopists at six partic...
Eligibility Criteria
Inclusion
- All adult patients (aged ≥ 18years)
- Active UGIB who arrived at emergency room (ER) and had a schedule for EGD within 12 hours after onset of bleeding ; Active UGIB was defined as having hematemesis or fresh blood by diagnostic gastric lavage at the ER.
Exclusion
- known allergy to metoclopramide
- prior gastric or duodenal surgery
- known case of esophageal, gastric or duodenal cancer;
- advanced HIV infection (defined as WHO criteria13-15: CD4 \<200 cell/mm3 or WHO clinical stage 3 or 4)
- pregnancy
- gastric lavage was performed with solution \> 50 ml.
Key Trial Info
Start Date :
October 1 2023
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
June 30 2025
Estimated Enrollment :
220 Patients enrolled
Trial Details
Trial ID
NCT06167837
Start Date
October 1 2023
End Date
June 30 2025
Last Update
December 13 2023
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
King Chulalongkorn memorial hospital
Bangkok, Thailand, 10330
2
King Chulalongkorn Memorial hospital
Bangkok, Thailand, 10330